Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study

BMC Gastroenterology

Wen-Chi Chen²  Chia-Ing Li⁵  Shih-Wei Lai¹  Kuan-Fu Liao³  Shih-Chang Hung⁴ 

[1] Department of Family Medicine, China Medical University Hospital, Taichung, 404, Taiwan;Department of Urology, China Medical University Hospital, Taichung, 404, Taiwan;School of Medicine, Tzu Chi University, Hualien, 970, Taiwan;Department of Public Health, China Medical University, Taichung, 404, Taiwan;Department of Medical Research, China Medical University Hospital, Taichung, 404, Taiwan

关键词: obesity;    menopause;    hyperlipidemia;    hepatitis C;    hepatitis B;    cholelithiasis;   

Others  :  1113237
DOI  :  10.1186/1471-230X-11-111

 received in 2011-05-19, accepted in 2011-10-17,  发布年份 2011

【 摘 要 】

Background

Cholelithiasis has become a major health problem in Taiwan. The predominant type of gallstone found in Asian populations differs from that in the West, indicating possible differences in the etiology and risk factors for cholelithiasis. The aim of this study is to investigate the risk factors for cholelithiasis using data representative of the general population.

Methods

We performed a population-based, case-control study in which we analyzed medical data for 3725 patients newly diagnosed with cholelithiasis and 11175 gender- and age-matched controls with no history of cholelithiasis, using information obtained from the 2005 Registry for Beneficiaries of the National Health Insurance Research Database. Coexisting medical conditions were included in the analysis. Relative risks were estimated by adjusted odds ratio (OR) and 95% confidence interval (CI) using a multivariate logistic regression analysis.

Results

After controlling for the other covariates, multivariate logistic regression analysis identified the following as risk factors for cholelithiasis (in descending order of contribution): Among all patients - hepatitis C (OR = 2.78), cirrhosis (OR = 2.47), hepatitis B (OR = 2.00), obesity (OR = 1.89), and hyperlipidemia (OR = 1.54); Among women - hepatitis C (OR = 3.05), cirrhosis (OR = 1.92), obesity (OR = 1.91), menopause (OR = 1.61), hepatitis B (OR = 1.54), and hyperlipidemia (OR = 1.49). Diabetes mellitus appeared to have a marked influence on the development of cholelithiasis but was not identified as a significant independent risk factor for cholelithiasis.

Conclusions

The risk factors for cholelithiasis were obesity, hyperlipidemia, hepatitis B infection, hepatitis C infection, and cirrhosis in both genders, and menopause in females. Despite differences in the predominate type of gallstone in Asian versus Western populations, we identified no unique risk factors among the population of Taiwan.

【 授权许可】

   
2011 Hung et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Bodmer M, Brauchli YB, Krahenbuhl S, Jick SS, Meier CR: Statin use and risk of gallstone disease followed by cholecystectomy. JAMA 2009, 302(18):2001-2007.
• [2]Guss DA, Oyama LC: Disorders of the Liver and Biliary Tract. In Rosen's Emergency Medicine: Concepts and Clinical Practice. 7th edition. Edited by John Marx RH, Ron Walls. Philadelphia: Mosby; 2010.
• [3]Wittenburg H, Lammert F: Genetic predisposition to gallbladder stones. Semin Liver Dis 2007, 27(1):109-121.
• [4]Shaffer EA: Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006, 20(6):981-996.
• [5]Shaffer EA: Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005, 7(2):132-140.
• [6]Acalovschi M, Buzas C, Radu C, Grigorescu M: Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. J Viral Hepat 2009, 16(12):860-866.
• [7]Huang J, Chang CH, Wang JL, Kuo HK, Lin JW, Shau WY, Lee PH: Nationwide epidemiological study of severe gallstone disease in Taiwan. BMC Gastroenterol 2009, 9:63. BioMed Central Full Text
• [8]Liu CM, Tung TH, Liu JH, Lee WL, Chou P: A community-based epidemiologic study on gallstone disease among type 2 diabetics in Kinmen, Taiwan. Dig Dis 2004, 22(1):87-91.
• [9]Ho KJ, Lin XZ, Yu SC, Chen JS, Wu CZ: Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci 1995, 40(9):1963-1973.
• [10]Tazuma S: Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol 2006, 20(6):1075-1083.
• [11]Yoo EH, Oh HJ, Lee SY: Gallstone analysis using Fourier transform infrared spectroscopy (FT-IR). Clin Chem Lab Med 2008, 46(3):376-381.
• [12]Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, Yeh YH, Wu HS, Chou DA, Yueh SK: Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol 2006, 21(11):1737-1743.
• [13]Chen CY, Lu CL, Lee PC, Wang SS, Chang FY, Lee SD: The risk factors for gallstone disease among senior citizens: an Oriental study. Hepatogastroenterology 1999, 46(27):1607-1612.
• [14]Liew PL, Wang W, Lee YC, Huang MT, Lin YC, Lee WJ: Gallbladder disease among obese patients in Taiwan. Obes Surg 2007, 17(3):383-390.
• [15]Tung TH, Ho HM, Shih HC, Chou P, Liu JH, Chen VT, Chan DC, Liu CM: A population-based follow-up study on gallstone disease among type 2 diabetics in Kinmen, Taiwan. World J Gastroenterol 2006, 12(28):4536-4540.
• [16]Liu CM, Tung TH, Chou P, Chen VT, Hsu CT, Chien WS, Lin YT, Lu HF, Shih HC, Liu JH: Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital. World J Gastroenterol 2006, 12(8):1281-1286.
• [17]Lu JF, Hsiao WC: Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood) 2003, 22(3):77-88.
• [18]International Classification of Diseases, Ninth Revision (ICD-9). Centers for Disease Control and Prevention Web site [http://www.cdc.gov/nchs/icd/icd9.htm] webcite
• [19]Meshikhes AW: Asymptomatic gallstones in the laparoscopic era. J R Coll Surg Edinb 2002, 47(6):742-748.
• [20]Ayantunde AA, Agrawal A: Gallstone ileus: diagnosis and management. World J Surg 2007, 31(6):1292-1297.
• [21]Gasparrini M, Liverani A, Catracchia V, Conte S, Leonardo G, Marino G, Milillo A, Mari FS, Pezzatini M, Favi F: Gallstone ileus: a case report and review of the literature. Chir Ital 2008, 60(5):755-759.
• [22]Lu SN, Chang WY, Wang LY, Hsieh MY, Chuang WL, Chen SC, Su WP, Tai TY, Wu MM, Chen CJ: Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey. J Clin Gastroenterol 1990, 12(5):542-546.
• [23]Sheen IS, Liaw YF: The prevalence and incidence of cholecystolithiasis in patients with chronic liver diseases: a prospective study. Hepatology 1989, 9(4):538-540.
• [24]Gonzalez M, Toso C, Zufferey G, Roiron T, Majno P, Mentha G, Morel P: When should cholecystectomy be practiced? Not always an easy decision. Rev Med Suisse 2006, 2(70):1586-1592.
• [25]Schirmer BD, Winters KL, Edlich RF: Cholelithiasis and cholecystitis. J Long Term Eff Med Implants 2005, 15(3):329-338.
• [26]Brady WJ, Aufderheide TP, Tintinalli JE: Cholecystitis and Biliary Colic. In Tintinalli's Emergency Medicine: A Comprehensive Study Guide. 6th edition. Edited by Tintinalli JE KG, Staphczynski JS. New York: McGraw-Hill; 2004:561-565.
• [27]Portincasa P, Moschetta A, Palasciano G: Cholesterol gallstone disease. Lancet 2006, 368(9531):230-239.
• [28]Diehl AK, Schwesinger WH, Holleman DR Jr, Chapman JB, Kurtin WE: Clinical correlates of gallstone composition: distinguishing pigment from cholesterol stones. Am J Gastroenterol 1995, 90(6):967-972.
• [29]Chen CY, Lu CL, Huang YS, Tam TN, Chao Y, Chang FY, Lee SD: Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing 1998, 27(4):437-441.
• [30]Barut I, Tarhan OR, Baykal B, Demir M, Celikbas B: Higher incidence of cholelithiasis in chronic renal failure patients with secondary hyperparathyroidism undergoing peritoneal dialysis. Ren Fail 2007, 29(4):453-457.
• [31]Zak A, Zeman M, Hrubant K, Vecka M, Tvrzicka E: Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease. Cas Lek Cesk 2007, 146(1):24-34.
• [32]Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, et al.: Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000, 15(12):1356-1361.
• [33]Nobili V, Day C: Childhood NAFLD: a ticking time-bomb? Gut 2009, 58(11):1442.
• [34]Acalovschi M: Cholesterol gallstones: from epidemiology to prevention. Postgrad Med J 2001, 77(906):221-229.
• [35]Ostrowska L, Czapska D, Karczewski JK: Body weight gain as the major risk factor of cholelithiasis in women and an important risk factor in man. Rocz Akad Med Bialymst 2005, 50(Suppl 1):54-56.
• [36]Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553.
• [37]Misciagna G, Leoci C, Guerra V, Chiloiro M, Elba S, Petruzzi J, Mossa A, Noviello MR, Coviello A, Minutolo MC, et al.: Epidemiology of cholelithiasis in southern Italy. Part II: Risk factors. Eur J Gastroenterol Hepatol 1996, 8(6):585-593.
• [38]Mendez Sanchez N, Uribe Esquivel M, Jessurun Solomou J, Cervera Ceballos E, Bosques Padilla F: Epidemiology of gallstone disease in Mexico. Rev Invest Clin 1990, (42 Suppl):48-52.
• [39]Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL: Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men. Gut 2005, 54(6):823-828.
• [40]Tazuma S, Kajiyama G, Mizuno T, Yamashita G, Miura H, Kajihara T, Hattori Y, Miyake H, Nishioka T, Hyogo H, et al.: A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy. J Clin Gastroenterol 1998, 26(4):287-291.
• [41]Ruhl CE, Everhart JE: Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000, 31(2):299-303.
• [42]Pacchioni M, Nicoletti C, Caminiti M, Calori G, Curci V, Camisasca R, Pontiroli AE: Association of obesity and type II diabetes mellitus as a risk factor for gallstones. Dig Dis Sci 2000, 45(10):2002-2006.
• [43]Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM: Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005, 71(2):97-105.
• [44]Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC: Effect of estrogen therapy on gallbladder disease. JAMA 2005, 293(3):330-339.
• [45]Lai SW, Liao KF, Lai HC, Chou CY, Cheng KC, Lai YM: The prevalence of gallbladder stones is higher among patients with chronic kidney disease in Taiwan. Medicine (Baltimore) 2009, 88(1):46-51.
• [46]Momiyama M, Wakai K, Oda K, Kamiya J, Ohno Y, Hamaguchi M, Nakanuma Y, Hsieh LL, Yeh TS, Chen TC, et al.: Lifestyle risk factors for intrahepatic stone: findings from a case-control study in an endemic area, Taiwan. J Gastroenterol Hepatol 2008, 23(7 Pt 1):1075-1081.